Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands

BACKGROUND: Response-guided neoadjuvant chemotherapy (RG-NACT) with magnetic resonance imaging (MRI) is effective in treating oestrogen receptor positive/human epidermal growth factor receptor-2 negative (ER-positive/HER2-negative) breast cancer. We estimated the expected cost-effectiveness and reso...

Descripción completa

Detalles Bibliográficos
Autores principales: Miquel-Cases, Anna, Steuten, Lotte M. G., Rigter, Lisanne S., van Harten, Wim H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011796/
https://www.ncbi.nlm.nih.gov/pubmed/27595620
http://dx.doi.org/10.1186/s12885-016-2653-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011796/
https://www.ncbi.nlm.nih.gov/pubmed/27595620
http://dx.doi.org/10.1186/s12885-016-2653-y

Ejemplares similares